ARCHIVES

Regulatory Agencies: Groups Petition FDA To Ease Silicone Gel Implant Restrictions

This article is from The Cancer Letter archive.

Vol. 22 No. 37 | September 27, 1996

Download PDF Visit The Full Archive

Related Articles

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials.

October 15, 2004

NCI R01 Payline At 22nd Percentile, Plans To Cut Large R01 Budgets By 18 Percent.

February 23, 2001

AACR 2014 Cancer Progress Report: More Federal Funds Needed

September 19, 2014

Arzerra Given Accelerated Approval For Leukemia

October 30, 2009

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013